And thats close to 1billion syringes if I am not mistaken - growing at 15-25% per year. By the time the production facility is complete, it will not be able to supply 100% of Sanofi's requirements for RTFS. So I expect a much bigger extension further down the track (which is not a part of the current plans)
Sanofi should provide 50% of Unilife's revenue. The others will contribute the other $1billion+
- Forums
- ASX - By Stock
- UNS
- enough drama
enough drama, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)